Search J Rheum

Advanced Search

Home

Current Issue

Archives

Guidelines for Authors & Reviewers

Classified Ads

Links

Search PubMed

Subscriptions

Subscriber Registration

Guidelines for Website Users

JRheum Update Service

Contact Info


Read Full Text


Download PDF


View Table of Contents

Circulating Cytokine Levels Compared to Pain in Patients with Fibromyalgia — A Prospective Longitudinal Study Over 6 Months

HAILI WANG, MICHAEL MOSER, MARCUS SCHILTENWOLF, and MATTHIAS BUCHNER

ABSTRACT.

Objective.
This prospective study examined circulating cytokines in patients with fibromyalgia (FM) over 6 months rather than at only one timepoint, and investigated correlations between serum cytokine concentrations and pain intensity in FM patients receiving multidisciplinary pain therapy.

Methods. Serum concentrations of proinflammatory cytokines interleukin 6 (IL-6), IL-8, and tumor necrosis factor-α (TNF-α) and antiinflammatory cytokines IL-4 and IL-10 were measured (Bio-Plex system) in 20 FM patients and 80 healthy subjects on admission and 10, 21, and 180 days after initiation of treatment and correlated to pain intensity.

Results. On admission, serum levels of IL-8 (p < 0.001) and TNF-α (p < 0.001), but not IL-6, were elevated in patients with FM. No significant difference in IL-4 and IL-10 was found between FM patients and controls. High IL-8 levels remained consistent during the followup, but TNF-α was already reduced after 10 days and until 6 months after therapy. After 6 months' treatment with multidisciplinary pain therapy, IL-8 and TNF-α levels were significantly lower than at the beginning (p < 0.05 for IL-8, p < 0.001 for TNF-α). IL-8 but not TNF-α serum levels were correlated with pain intensity (r = –0.782, p = 0.001) in FM patients after 6 months' multidisciplinary pain therapy.

Conclusion. Our results suggest that proinflammatory cytokines TNF-α and IL-8 are involved in FM, but they do not apparently provoke the pain of FM directly. Multidisciplinary pain therapy modified the cytokine profile in patients with FM during the observation period. (First Release June 1 2008; J Rheumatol 2008;35:1366-70)

Key Indexing Terms:

PROSPECTIVE STUDY
FIBROMYALGIA
CYTOKINE PROFILE
SERUM LEVEL


From the Department of Orthopaedic Surgery, Ruprecht-Karls-University of Heidelberg, Heidelberg; and SRH Klinikum Karlsbad-Langensteinbach, Karlsbad, Germany.

H. Wang, MD; M. Moser; M. Schiltenwolf, MD, Professor, Department of Orthopaedic Surgery, Ruprecht-Karls-University; M. Buchner, MD, PhD, SRH Klinikum Karlsbad-Langensteinbach.

Address reprint requests to Dr. H. Wang, Department of Orthopaedic Surgery, Ruprecht-Karls-University of Heidelberg, Schlierbacher Landstrasse 200 A, 69118 Heidelberg, Germany. E-mail: haili.wang@ok.uni-heidelberg.de

Accepted for publication February 26, 2008.




Return to July 2008 Table of Contents



© The Journal of Rheumatology Publishing Company Limited.
All rights reserved.